A Study of Tor Kinase Inhibitor in Advanced Tumors
NCT00731263
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
64
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
AZD8055
Sponsor
AstraZeneca